Molecular landscape of the spliceosome cohort. (A) Oncoprint of molecular mutations in patients with spliceosome mutations. (B) Frequency and associated amino acid substitution of included spliceosome mutations. (C) Variant allele frequency (VAF) of recurrently mutated genes in patients with SRSF2 and IDH2 co-mutations.